BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 7, 2001
View Archived Issues
Novartis R&D day 2001: solid platform for sustained growth
Read More
Human monoclonal antibody LymphoStat-B enters clinical testing for autoimmune disease
Read More
Phase III trial plans announced for secretin in autism
Read More
Novartis seeks European marketing authorization for Myfortic
Read More
Boston Life Sciences' Troponin I passes toxicology tests
Read More
Meningitis vaccines near commercialization in Canada
Read More
Milestone in ALX-0646 migraine program
Read More
Phase III results for Aldurazyme support marketing approval application
Read More
Second Phase I grant awarded to Metabasis for liver disease research
Read More
Vaccines for chronic diseases jointly researched by Novartis and Cytos
Read More
Monoclonal antibody targeting human FLT-1 effective in human breast cancer xenograft model
Read More
AP-5280, a polymer-linked platinum antitumor agent, shows promising preclinical activity
Read More
XR-9576 tested in combination with vinorelbine in heavily pretreated cancer patients
Read More
First report of potent and selective inhibitors of c-Src protein tyrosine kinase identified at Ariad
Read More
Therapeutic antitumor potential of JNK inhibitors documented by Celgene
Read More
Ertapenem profiled at the IDSA meeting
Read More
Company Profile: TolerRx
Read More
Ranbaxy synthesizes new antifungal agents
Read More
Two patents cover GSK's new Raf kinase inhibitors and uses thereof
Read More
Inhibitors of FBPase useful for diabetes and related conditions
Read More
Potent LHRH antagonists with improved properties patented by Zentaris
Read More
Inhibitors of VLA-4-mediated cell adhesion disclosed by Aventis
Read More
New CB1 antagonists prepared by Aventis
Read More
